As a first step to framework modernization, the Patented Medicines Prices Review Board (PMPRB) is undertaking major consultations regarding possible ... Read More
Effective December 1, 2016, all new Special Authorization requests for the treatment of Moderately to Severely Active Crohn's Disease and ... Read More
The Patented Medicine Prices Review Board (PMPRB) announced the reappointment of Dr. Mitchell Levine of Hamilton, Ontario as Vice-chairperson of ... Read More
INESSS Upcoming Meetings with Manufacturers – June 2017 “Liste des médicaments”
INESSS is offering an opportunity for in-person meetings to manufacturers ... Read More
Effective November 1, 2016, the ministry is introducing the application of generic substitution to the Exceptional Access Program (EAP).
Under this ... Read More
